#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extraskeletal ossification T-cell lymphoma Leiomyosarcoma Graft versus host disease Skin cancer Ovarian cancer stage III Malignant neoplasm of choroid Rett syndrome Hereditary ataxia Congenital disorder of glycosylation Rhabdomyosarcoma recurrent Liver abscess Immunoglobulin G4 related disease Medullary thyroid cancer Kidney transplant rejection More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Diagnostics Haemophagocytic lymphohistiocytosis – Treatment Alport’s syndrome – Basic Information Retinitis pigmentosa – Life with Disease Glomerulonephritis membranous – Basic Information Kearns-Sayre syndrome – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Noonan syndrome – Basic Information Paroxysmal nocturnal haemoglobinuria – Treatment Fragile X syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Adapalene Aztreonam Filgrastim Tiotropium Alemtuzumab Charcoal, Activated Ficlatuzumab Clofazimine Gen1047 TUVATEXIB Ephedrine Hydrochloride Nacystelyn Anthoxanthum Odoratum Pehero Enoxaparin Sodium Medi0618 D-Biotin Hydrocortisone Ph. Eur. Sertindole SODIUM DIHYDROGEN PHOSPHATE More therapies…

    Learn about Your Condition

    Laparoscopic surgery Cystic fibrosis Prostatitis Escherichia coli Axial spondyloarthritis Hypersomnia Hepatitis B Acute coronary syndrome Hand dermatitis Vasoplegia syndrome Embolic stroke Skin neoplasm excision Retinitis pigmentosa Atrophic vulvovaginitis Congenital ureteric anomaly Glomerulonephritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study of Ipilimumab, Nivolumab and Melphalan combination therapy with hepatic perfusion in patients with advanced uveal melanoma that has spread to other organs

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Melphalan
    • Ipilimumab
    • Nivolumab
    The Netherlands

  • Study on the Effects of Finerenone and SGLT2 Inhibitors on Heart and Kidney Health in Patients with Type 2 Diabetes and Chronic Kidney Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Denmark

  • Title: Comparing tebentafusp treatment versus observation in patients with high-risk eye melanoma (uveal melanoma) after initial treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tebentafusp
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study on Reducing Inflammation After Cataract Surgery Using Nepafenac and Dexamethasone for Patients Undergoing Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Nepafenac
    • Dexamethasone
    Norway

  • Comparison of hydrocortisone and dexamethasone eye drops for treating inflammatory conjunctival secretions in patients with ocular prostheses

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Povidone
    • Hydrocortisone Sodium Phosphate
    • Dexamethasone Phosphate
    France

  • Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Retinal artery occlusion
    Investigated Drugs:
    • Sodium Chloride
    • Acetylsalicylic Acid
    • Tenecteplase
    Belgium Denmark Finland Ireland Norway Sweden
Previous Page
1 … 6 7 8 9 10 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!